Patients with Hashimoto’s encephalopathy (HE), a steroid-responsive disorder, associated with Hashimoto’s disease and high levels of thyroid-related autoantibodies usually present with a subacute onset of confusion, focal or generalized seizures. Frequent EEG abnormalities include generalized, rhythmic bifrontal or temporal slowing. Elevated protein levels or an intrathecal IgG synthesis may be present in cerebrospinal fluid (CSF). A 39-year-old woman underwent a relapsing course of myocloni and generalized seizures. Initially, thyroid function, thyroid-related autoantibody screening and cerebral MRI were unrevealing. CSF showed oligoclonal bands. Short-term treatment with high doses of prednisolone resolved the myocloni. During the 5th episode of myocloni, signs of hyperthyroidism and elevation of thyroid microsomal antibody titer developed. Hashimoto’s thyroiditis and HE were diagnosed. After subtotal thyroidectomy the patient remained asymptomatic.

1.
Singer P: Thyroiditis: Acute, subacute and chronic. Med Clin North Am 1991;75:61–77.
2.
Shaw PJ, Wallis TJ, Newman PK, Cleland PG, Cartlidge NEF: Hashimoto’s encephalopathy: A steroid responsive disorder associated with high anti-thyroid antibody titers – Report of 5 cases. Neurology 1991;41:228–233.
3.
Cremer G, Goldstein N: Myxedema and ataxia. Neurology 1969;19:37–46.
4.
Manto M, Goldman S, Bodur H: Cerebellar syndrome associated with Hashimoto’s encephalopathy. Rev Neurol Paris 1996;152:202–204.
5.
Hall RCW, Popkin MK, Devaul R, Hall AK, Gardner ER, Beresford TP: Psychiatric manifestations of Hashimoto’s thyroiditis. Psychosomatics 1982:23:337–342.
6.
Whybrow P, Prange A, Treadway C: Mental changes accompanying thyroid gland dysfunction. Arch Gen Psychiatry 1969;20:48–63.
7.
Jellinek EH: Fits, faints, coma and dementia in myxoedema. Lancet 1962;ii:1010–1012.
8.
Shein M, Apter K, Dickerman Z, Tyano S, Gadoth N: Encephalopathy in compensated Hashimoto’s thyroiditis: A clinical expression of autoimmune cerebral vasculitis. Brain Dev 1986;8:60–64.
9.
Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL: Electroencephalographic findings in Hashimoto’s encephalopathy. Neurology 1995;45:977–981.
10.
Brain L, Jellinek E, Ball K: Hashimoto’s disease and encephalopathy. Lancet 1966;ii:512–514.
11.
Thrush D, Boddie H: Episodic encephalopathy associated with thyroid disorders. J Neurol Neurosurg Psychiatry 1974;37:696–700.
12.
Kruse H: Thyrotropin-releasing hormone: Interaction with chlorpromazine in mice, rats and rabbits. J Pharmacol 1975;6:249–268.
13.
Brown M, Vale W: Central nervous system effects of hypothalamic peptides. Endocrinology 1975;96:1333–1336.
14.
Mauriac L, Roger P, Kern AM, Manciet G, Rivière L, Henry P: Thyroïdite de Hashimoto et encéphalopathie. Rev Fr Endocrinol Clin 1982;23:147–150.
15.
Maeda K, Tanimoto K: Epileptic seizures induced by thyrotropin-releasing hormone. Lancet 1981;i:1058–1059.
16.
Latinville D, Bernardi O, Cougoule JP, Bioulac B, Henry P, Loiseau P, Mauriac L: Thyroidite d’Hashimoto et encéphalopathie myoclonique. Hypothèses pathogéniques. Rev Neurol 1992;141:55–58.
17.
Henderson LM, Behan PO, Aarli J, Hadley D, Draper D: Hashimoto’s encephalopathy: A new neuroimmunologic syndrome. Ann Neurol 1987;22:140–141.
18.
Shaw PJ, Bates D, Kendall-Taylor P: Hyperthyroidism presenting as pyramidal tract disease. Br Med J 1988;297:1395–1396.
19.
Ghawche F, Bordet R, Destee A: Encéphalopathie d’Hashimoto: toxique ou auto-immune? Rev Neurol 1992;148:371–373.
20.
Ghika-Schmid F, Ghika J, Regli F, Dworak N, Bogousslavsky J, Städler C, Portmann L, Despland PA: Hashimoto’s myoclonic encephalopathy. An underdiagnosed treatable condition? Mov Disord 1996;11:555–562.
21.
Ishii K, Hayashi A, Tamaoka A, Usuki S, Mizusawa H, Shoji S: Case report: Thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto’s encephalopathy. Am J Med Sci 1995;310:202–205.
22.
Sue CM, Morris JGL: Another case of Hashimoto’s encephalopathy. Mov Disord 1997;12:471–472.
23.
Bohnen NILJ, Parnell KJ, Harper CM: Reversible MRI findings in a patient with Hashimoto’s encephalopathy. Neurology 1997;49:246–247.
24.
Lebuscher H, Herrmann F, Hambsch K, Langpeter D, Mueller P, Sorger D: EEG changes in untreated hyperthyroidism and under the conditions of thyreostatic treatment. Exp Clin Endocrinol 1988;92:85.
25.
Kasagi K, Matsumoto S, Takeuchi R, Misaki T, Konishi J: Transient thyrotoxicosis in a patient with a functioning nodule: A possible occurrence of silent thyroiditis. Ann Nucl Med 1992;6:117–120.
26.
Engler H, Riesen W, Keller B: Anti-thyroid peroxidase (anti-TPO) entibodies in thyroid diseases, non-thyroidal illness and controls: Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Clin Chim Acta 1994;225:123–136.
27.
Volpé R. Autoimmune thyroiditis; in Braverman LU (ed): The Thyroid. Philadelphia, Lippincott, 1991, vol 1, pp 921–933.
28.
Hawkins BR, Cheah PS, Dawkins RL, Whittingham S, Burger HG, Patel Y, Mackay IR, Welborn TA: Diagnostic significance of thyroid microsomal antibodies in a randomly selected population. Lancet 1980;ii:1057–1059.
29.
Loeb P, Drash A, Kenney F: Prevalence of low titre and ‘negative’ antithyrogobulin antibodies in biopsy-proven juvenile Hashimoto’s thyroiditis. J Pediatr 1973;82:17.
30.
Bastenie PA: Autoimmune thyroiditis, Hashimoto’s goitre, and premyxoedema. Lancet 1978;i:1369.
31.
Jannson R, Karlsson A, Dahlberg P: Thyroxine, methimazole and thyroid microsomal autoantibody titres in hypothyroid Hashimoto’s thyroiditis. Br Med J 1985;290:11–12.
32.
Volpé R: Autoimmune thyroid disease; in Volpé R (ed): Autoimmunity and Endocrine Disease. New York, Marcel Dekker, 1985, p 109.
33.
Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y: Association of serum antithyroidal antibodies with lymphocytic infiltration of the thyroid gland: Study of 70 autopsied cases. J Clin Endocrinol Metab 1978;46:459.
34.
O’Regan S, Fong J, Kaplan B, De Chadarevian J, Lapointe N, Drummond K: Thyroid antigen-antibody nephritis. Clin Immunol Immunopathol 1976;6:341–346.
35.
Jordan S, Johnston W, Bergstein J: Immune complex glomerulonephritis mediated by thyroid antigens. Arch Pathol Lab Med 1978;102:530–533.
36.
Awaki E, Onoda K, Takahashi K, Tanaka J: A case of chronic thyroiditis associated with vasculitic neuropathy. Clin Neurol 1988;28:501–506.
37.
Royce PC: Severely impaired consciousness in myxedema. Am J Med Sci 1971;261:46–50.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.